Subclinical Cognitive Deficits in Cancer Patients: A Preliminary P300 Study

Folstein MF Fetting JH Lobo . Cognitive assessment of cancer patients. Cancer 1984; 53: 2250–2257.

Fleishman S Lesko LM . Delirium and dementia. In: Holland JC Rowland JH (eds). Handbook of Psychooncology (Psychological care of the patient with cancer). Oxford University Press; 1989:342–355.

Silverfarb PM Philibert D Levine PM . Psychosocial aspects of neoplastic disease: affective and cognitive effects of chemotherapy in cancer patients. Am J Psychiat 1980; 137: 597–601.

Silverfarb PM Oxman TE . The effect of cancer therapies on the central nervous system. In: Goldberg RJ (ed). Psychiatric Aspects of Cancer. Basel: Karger; 1988: 13–26.

Carde P Mackintosh R Rosenberg SA . A dose and time response analysis of the treatment of Hodgkin's disease with MOPP therapy. J Clin Oncology 1983; 1: 146–153.

Levin PM Silverfarb PM Lipowski ZJ . Mental disorders in cancer patients: a study of 100 psychiatric referrals. Cancer 1978; 43: 1385–1391.

Posner JB . Delirium and steroid psychosis: prevalence, diagnosis and management. In: Current Concepts in Psychological Oncology. New York: Sloan-Kettering Cancer Center; 1982.

Blot WJ Davies JE Brown LM . Occupation and the high risk of lung cancer in northeast Florida. Cancer 1982; 50: 364–371.

Deshmukh VD . Logistic patterning of brain activity. Clin Electroencephalogr 1989; 20: 266–272.

Celesia GG . Clinical utility of long latency cognitive’ event-related potentials (P3): Editorial comment. Electroencephalogr Clin Neurophysiol 1990; 76: 1.

Patchell RA Posner JB . Cancer and the nervous system. In: Holland JC Rowland JH (eds). Handbook of Psychooncology. Oxford University Press; 1985:327–341.

Anderson NE Cunningham JM Posner JB . Autoimmunopathogenesis of paraneoplastic neurological syndromes. CRC Critical Review of Neurology 1987:245–299.

Copeland DR Dowell RG Fletcher JM . Neuropsychological effects of childhood cancer treatment. J Child Neurology 1988; 3: 53–62.

Goodin DS . Clinical utility of long latency ‘cognitive’ event-related potentials (P3): the pros. Electroencephalogr Clin Neurophysiol 1990; 76: 2–5.

Pfefferbaum A Ford JM Kraemer H . Clinical utility of long latency ‘cognitive’ event-related potentials (P3): the cons. Electroencephalogr Clin Neurophysiol 1990; 76: 6–12.

Pfefferbaum A Ford JM Wenegrat BG . Clinical application of the P3 component of eventrelated potentials: normal aging. Electroencephalogr Clin Neurophysiol 1984; 59: 85–103.

Ito J Yamao S Fukuda H Mimori Y Nakamura S . The P300 event-related potentials in dementia of the Alzheimer's type: correlations between P300 and monoamine metabolites. Electroencephalogr Clin Neurophysiol 1990; 77: 174–178.

Polich J Ladish C Bloom FE . P300 assessment of early Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1990; 77: 179–189.

Finley WW Fox SF Hutcheson J Amstutz L . Long-latency event-related potentials in the evaluation of cognitive function in children. Neurology 1985; 35: 323–327.

Fukai M Motomura N Kobayashi S Asaba H Sakai T . Event-related potential (P300) in epilepsy. Acta Neurol Scand 1990; 82: 197–202.

Drake ME Jr. Pakalnis A Phillips B Padamadan H Hietter SA . Auditory evoked potentials in anxiety disorder. Clin Electroencephalogr 1991; 22: 97–101.

Triantafyllou NI Voumvourakis I Zalonis K . Cognition in relapsing-remitting multiple sclerosis: a multichannel event-related potential (P300) study. Acta Neurol Scand 1992; 85: 10–13.

Verleger R Neukater W Kompf D Vieregge P . On the reasons for the delay of P3 latency in healthy elderly subjects. Electroencephalogr Clin Neurophysiol 1991; 79: 488–502.